Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc.ARCT · Entity 5523 | Chief Legal Officer | December 17, 2025 | December 19, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arcturus Therapeutics Holdings Inc.
Report date December 17, 2025 · Filed December 19, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.52 · Expires 2035-12-17 | Direct | 54,000 |
Reported balance
After 2025-12-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-17 · Grant · Acquired 54,000 · Balance 54,000 F1: Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. F2: The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
F2: The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 17, 2025 Filed Dec 19, 2025 22:20 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantEmployee Stock Option (right to buy) · Derivative | 54,000 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0001193805-25-001764 · e665058_4-kurata.xml · derivative · entry 1 Kurata Lance · CIK 0001820961 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2035-12-17 F1 · shares: Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. F2 · derivative.exercise_date: The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:07 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $16.24 | $0.00 |
DisclosureSEC source: 0001193805-24-001493 · e664086_4-kurata.xml · derivative · entry 1 Kurata Lance · CIK 0001820961 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-12-16 F1 · shares: Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. F2 · derivative.exercise_date: The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 01:01 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $28.88 | $0.00 |
DisclosureSEC source: 0001193805-23-001628 · e619135_4-kurata.xml · derivative · entry 1 Kurata Lance · CIK 0001820961 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-12-15 F1 · shares: Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. F2 · derivative.exercise_date: The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:05 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $16.92 | $0.00 |
DisclosureSEC source: 0001193805-22-001713 · e618106_4-kurata.xml · derivative · entry 1 Kurata Lance · CIK 0001820961 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2032-12-09 F1 · shares: Represents options to purchase shares of common stock approved by the Board of Directors on December 9, 2022 pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. F2 · derivative.exercise_date: The shares underlying this option vest 25% on December 9, 2023, the first anniversary of the date this award was approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:15 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $34.57 | $0.00 |
DisclosureSEC source: 0001193805-22-000999 · e621770_4-kurata.xml · derivative · entry 1 Kurata Lance · CIK 0001820961 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-12-10 F1 · shares: Represents options to purchase shares of common stock conditionally approved by the Board of Directors on December 10, 2021, subject to approval of an amendment to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan by the Company's stockholders, which approval was obtained at the Company's 2022 Annual Meeting of Stockholders held on June 21, 2022. F2 · derivative.exercise_date: The shares underlying this option vest 25% on December 10, 2022, the first anniversary of the date this award was conditionally approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months. Read SEC document |
| December 18, 2020 Filed Dec 23, 2020 00:37 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $99.29 | $0.00 |
DisclosureSEC source: 0001193805-20-001606 · e620160_4-kurata.xml · derivative · entry 1 Kurata Lance · CIK 0001820961 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-12-18 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| August 10, 2020 Filed Aug 13, 2020 00:38 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantStock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $58.91 | $0.00 |
DisclosureSEC source: 0001193805-20-001022 · e619870_4-kurata.xml · derivative · entry 1 Kurata Lance · CIK 0001820961 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2030-08-09 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on August 10, 2021, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.